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AAEP Guidelines for Vaccination of Horses
The schedule below is a suggested vaccination schedule provided by the American Association of Equine Practitioners, and is based on generally accepted veterinary prac-
tices. These guidelines are neither regulations nor directives for all situations and should not be interpreted as such. It is the responsibility of attending veterinarians, through 
an appropriate veterinarian-client-patient relationship, to utilize this information coupled with available products to determine the best professional care for their patients. 
For complete discussion of vaccination guidelines, please see the AAEP resource guide “Guidelines for Vaccination of Horses” (the guide can be obtained by contacting the 
AAEP at <aaepofﬁce@aaep.org>).
Disease/vaccine Foals/weanlings Yearlings Performance Horses Pleasure Horses Broodmares Comments
West Nile Virus First dose: 3 to 4 months.
Second dose: 1 month 
later (plus 3rd dose at 6 
months in endemic areas).
Annual booster, prior to 
expected risk. Vaccinate 
semi-annually or more 
frequently (every 4 
months), depending 
on risk.
Annual booster, prior to 
expected risk. Vaccinate 
semi-annually or more 
frequently (every 4 
months), depending 
on risk.
Annual booster, prior to 
expected risk. Vaccinate 
semi-annually or more 
frequently (every 4 
months), depending 
on risk.
Annual.
4 to 6 weeks prepar-
tum (see full text in 
guidelines).
Annual booster is 
after primary series. In 
endemic areas, booster 
as required or warranted 
due to local conditions 
conducive to disease risk. 
Vaccinate semi-annually 
or more frequently (every 
4 months), depending 
on risk.
Tetanus toxoid From nonvaccinated 
mare: ﬁrst dose: 3 to 4 
months; second dose: 4 to 
5 months.
From vaccinated mare: 
ﬁrst dose: 6 months; 
second dose: 7 months; 
third dose: 8 to 9 months.
Annual. Annual. Annual. Annual, 4 to 6 weeks 
prepartum.
Booster at time of 
penetrating injury or 
surgery if last dose not 
administered within 6 
months.
Encephalomyelitis 
(EEE, WEE, VEE)
EEE (in high-risk areas): 
ﬁrst dose: 3 to 4 months; 
second dose: 4 to 5 
months; third dose: 5 to 6 
months.
Annual, spring. Annual, spring. Annual, spring. Annual, 4 to 6 weeks 
prepartum.
In endemic areas booster 
EEE and WEE every 6 
months; VEE only needed 
when threat of exposure; 
VEE may only be available 
as a combination vaccine 
with EEE and WEE.
WEE, EEE (in low-risk 
areas) and VEE: From 
nonvaccinated mare: ﬁrst 
dose: 3 to 4 months; 
second dose: 4 to 5 
months. From vaccinated 
mare: ﬁrst dose: 6 months; 
second dose: 7 months; 
third dose: 8 months.
Annual, spring. Annual, spring. Annual, spring. Annual, 4 to 6 weeks 
prepartum.
Inﬂuenza Inactivated injectable: 
From nonvaccinated mare: 
ﬁrst dose: 6 months; sec-
ond dose: 7 months; third 
dose: 8 months. Then at 
3-month intervals. From 
vaccinated mare: ﬁrst dose: 
9 months; second dose: 
10 months; third dose: 
11 to 12 months. Then at 
3-month intervals.
Every 3 to 4 months. Every 3 to 4 months. Annual with added 
boosters prior to likely 
exposure.
At least semiannually, with 
1 booster 4 to 6 weeks 
prepartum.
A series of at least 3 doses 
is recommended for 
primary immunization of 
foals. Not recommended 
for pregnant mares 
until data available. Use 
inactivated vaccine for 
prepartum booster. If ﬁrst 
dose is administered to 
foals less than 11 months 
of age, administer 2nd 
dose at or after 11 months 
of age.
Intranasal modiﬁed 
live virus: First dose: 11 
months; has been safely 
administered to foals less 
than 11 months—see 
comments.
Every 6 months. Every 6 months. Every 6 months. Annual before breeding 
(see comments).
Rhinopneumonitis 
(EHV-1 and EHV-4)
First dose: 4 to 6 months; 
second dose 5 to 7 
months; third dose: 6 to 8 
months. Then at 3-month 
intervals.
Booster every 3 to 4 
months up to annually.
Booster every 3 to 4 
months up to annually.
Optional: semiannual if 
elected.
Fifth, seventh, ninth 
month of gestation 
(inactivated EHV-1 
vaccine); optional dose at 
third month of gestation.
Vaccination of mares 
before breeding and 4 
to 6 weeks prepartum is 
suggested. Breeding stal-
lions should be vaccinated 
before the breeding season 
and semiannually.
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Disease/vaccine Foals/weanlings Yearlings Performance Horses Pleasure Horses Broodmares Comments
Strangles Injectable: ﬁrst dose: 4 to 
6 months; second dose: 5 
to 7 months; third dose: 7 
to 8 months (depending 
on the product used); 
fourth dose: 12 months.
Semiannual. Optional: semiannual if 
risk is high.
Optional: semiannual if 
risk is high.
Semiannual with 1 dose 
of inactivated M-protein 
vaccine 4 to 6 weeks 
prepartum.
Vaccines containing 
M-protein extract may 
be less reactive than 
whole-cell vaccines. Use 
when endemic conditions 
exist or risk is high. Foals 
as young as 6 weeks of 
age may safely receive 
the intranasal product. 
A third dose should be 
administered 2 to 4 weeks 
prior to weaning.
Rabies Foals born to non-
vaccinated mares: ﬁrst 
dose: 3 to 4 months; 
second dose: 12 months.
Foals born to vaccinated 
mares: ﬁrst dose: 6 
months; second dose: 7 
months; third dose: 12 
months.
Annual. Annual. Annual. Annual, before breeding. Vaccination recom-
mended in endemic areas. 
Do not use modiﬁed-live-
virus vaccines in horses.
Potomac Horse Fever First dose: 5 to 6 months; 
second dose: 6 to 7 
months.
Semiannual. Semiannual. Semiannual. Semiannual with 1 dose 4 
to 6 weeks prepartum.
Booster during May to 
June in endemic areas.
Botulism Foal from vaccinated 
mare: 3 dose series of 
toxoid at 30-day intervals 
starting at 2 to 3 months 
of age.
Foal from non-vaccinated 
mare: see comments.
Consult your veterinarian. Consult your veterinarian. Consult your veterinarian. Initial 3-dose series at 
30-day intervals with 
last dose 4 to 6 weeks 
prepartum. Annually 
thereafter, 4 to 6 weeks 
prepartum.
Only in endemic areas. A 
third dose administered 
4 to 6 weeks after the 
second dose may improve 
the response of foals to 
primary immunization.
Foal from non-vaccinated 
mare may beneﬁt from: 
1) toxoid at 2, 4, and 8 
weeks of age; 2) transfu-
sion of plasma from 
vaccinated horse; or 
3) antitoxin. Efﬁcacy 
needs further study.
Equine Viral Arteritis Intact colts intended to 
be breeding stallions: one 
dose at 6 to 12 months 
of age.
Annual for colts intended 
to be breeding stallions.
Annual for colts intended 
to be breeding stallions.
Annual for colts intended 
to be breeding stallions.
Annual for seronegative, 
open mares before breed-
ing to carrier stallions; 
isolate mares for 21 days 
after breeding to carrier 
stallion.
Annual for breeding stal-
lions and teasers, 28 days 
before start of breeding 
season; virus may be shed 
in semen for up to 21 
days. Vaccinated mares do 
not develop clinical signs 
even though they become 
infected and may shed 
virus for a short time.
Rotavirus A Little value to vaccinate 
foal because insufﬁcient 
time to develop antibodies 
to protect during 
susceptible age.
Not applicable. Not applicable. Not applicable. Vaccinate mares at 8, 
9, and 10 months of 
gestation, each pregnancy. 
Passive transfer of 
colostral antibodies aid 
in prevention of rotaviral 
diarrhea in foals.
Check concentrations of 
immunoglobulins in foal 
to be assured that there 
is no failure of passive 
transfer.
*As with all medications, the label and product insert should be read before administration of all vaccines.
Schedules for stallions should be consistent with the vaccination program of the adult horse population on the farm and modiﬁed according to risk.
EEE = eastern equine encephalomyelitis, WEE = western equine encephalomyelitis, VEE = Venezuelan equine encephalomyelitis, EHV-1 = equine herpes virus type.
